Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic interaction between pazopanib and cisplatin regimen.
Imbs DC, Diéras V, Bachelot T, Campone M, Isambert N, Joly F, Jimenez M, Lafont T, Chatelut E. Imbs DC, et al. Cancer Chemother Pharmacol. 2016 Feb;77(2):385-92. doi: 10.1007/s00280-015-2953-y. Epub 2016 Jan 16. Cancer Chemother Pharmacol. 2016. PMID: 26779916 Clinical Trial.
Pharmacokinetics of pazopanib administered in combination with bevacizumab.
Imbs DC, Négrier S, Cassier P, Hollebecque A, Varga A, Blanc E, Lafont T, Escudier B, Soria JC, Pérol D, Chatelut E. Imbs DC, et al. Cancer Chemother Pharmacol. 2014 Jun;73(6):1189-96. doi: 10.1007/s00280-014-2455-3. Epub 2014 Apr 6. Cancer Chemother Pharmacol. 2014. PMID: 24705975 Clinical Trial.
A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study.
Diéras V, Bachelot T, Campone M, Isambert N, Joly F, Le Tourneau C, Cassier P, Bompas E, Fumoleau P, Noal S, Orsini C, Jimenez M, Imbs DC, Chatelut E. Diéras V, et al. Among authors: imbs dc. Oncol Ther. 2016;4(2):211-223. doi: 10.1007/s40487-016-0027-x. Epub 2016 Aug 18. Oncol Ther. 2016. PMID: 28261651 Free PMC article.
Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer.
Barlesi F, Deyme L, Imbs DC, Cousin E, Barbolosi M, Bonnet S, Tomasini P, Greillier L, Galloux M, Testot-Ferry A, Pelletier A, André N, Ciccolini J, Barbolosi D. Barlesi F, et al. Among authors: imbs dc. Cancer Chemother Pharmacol. 2022 Aug;90(2):149-160. doi: 10.1007/s00280-022-04455-x. Epub 2022 Jul 22. Cancer Chemother Pharmacol. 2022. PMID: 35867144 Clinical Trial.
13 results